UroGen Pharma Ltd. (URGN)

USD 10.14

(-3.7%)

Total Assets Summary of UroGen Pharma Ltd.

  • UroGen Pharma Ltd.'s latest annual total assets in 2023 was 178.31 Million USD , up 30.88% from previous year.
  • UroGen Pharma Ltd.'s latest quarterly total assets in 2024 Q1 was 200.57 Million USD , up 12.49% from previous quarter.
  • UroGen Pharma Ltd. reported annual total assets of 136.23 Million USD in 2022, up 13.77% from previous year.
  • UroGen Pharma Ltd. reported annual total assets of 119.74 Million USD in 2021, down -1.85% from previous year.
  • UroGen Pharma Ltd. reported quarterly total assets of 281.84 Million USD for 2024 Q2, up 40.52% from previous quarter.
  • UroGen Pharma Ltd. reported quarterly total assets of 200.57 Million USD for 2024 Q1, up 12.49% from previous quarter.

Annual Total Assets Chart of UroGen Pharma Ltd. (2023 - 2013)

Historical Annual Total Assets of UroGen Pharma Ltd. (2023 - 2013)

Year Total Assets Total Assets Growth
2023 178.31 Million USD 30.88%
2022 136.23 Million USD 13.77%
2021 119.74 Million USD -1.85%
2020 122 Million USD -39.72%
2019 202.38 Million USD 95.43%
2018 103.55 Million USD 37.07%
2017 75.55 Million USD 227.68%
2016 23.05 Million USD 18.91%
2015 19.39 Million USD 344.83%
2014 4.35 Million USD 35.16%
2013 3.22 Million USD 0.0%

Peer Total Assets Comparison of UroGen Pharma Ltd.

Name Total Assets Total Assets Difference
AbCellera Biologics Inc. 1.48 Billion USD 88.017%
Alkermes plc 2.13 Billion USD 91.653%
Agenus Inc. 313.91 Million USD 43.197%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 95.344%
Aptorum Group Limited 20.64 Million USD -763.906%
Ardelyx, Inc. 297.57 Million USD 40.079%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 76.708%
Bicycle Therapeutics plc 595.34 Million USD 70.049%
BioXcel Therapeutics, Inc. 73.7 Million USD -141.935%
ChromaDex Corporation 54.96 Million USD -224.414%
Chimerix, Inc. 212.77 Million USD 16.197%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -530.689%
Caribou Biosciences, Inc. 440.96 Million USD 59.564%
CRISPR Therapeutics AG 2.22 Billion USD 92.002%
Precision BioSciences, Inc. 159.78 Million USD -11.597%
Dyadic International, Inc. 8.21 Million USD -2069.435%
Eton Pharmaceuticals, Inc. 31.74 Million USD -461.786%
Fortress Biotech, Inc. 167.52 Million USD -6.438%
Lantern Pharma Inc. 43.64 Million USD -308.524%
HOOKIPA Pharma Inc. 161.33 Million USD -10.521%
Inhibikase Therapeutics, Inc. 14.5 Million USD -1129.168%
Incyte Corporation 6.78 Billion USD 97.371%
IO Biotech, Inc. 150.71 Million USD -18.308%
Jaguar Health, Inc. 50.76 Million USD -251.262%
Novavax, Inc. 1.85 Billion USD 90.389%
Janux Therapeutics, Inc. 380.4 Million USD 53.126%
Opthea Limited 188.79 Million USD 5.551%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 78.596%
ContextLogic Inc. 423 Million USD 57.846%
MiMedx Group, Inc. 239.04 Million USD 25.408%
Pyxis Oncology, Inc. 173.72 Million USD -2.639%
TransCode Therapeutics, Inc. 5.16 Million USD -3349.155%
NextCure, Inc. 129.41 Million USD -37.779%
Ocuphire Pharma, Inc. 53.94 Million USD -230.524%
Oncternal Therapeutics, Inc. 36.72 Million USD -385.477%
Outlook Therapeutics, Inc. 32.3 Million USD -452.029%
Vaxcyte, Inc. 1.4 Billion USD 87.335%
PDS Biotechnology Corporation 59.39 Million USD -200.237%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 72.163%
Pharming Group N.V. 462.85 Million USD 61.476%
Pieris Pharmaceuticals, Inc. 38.68 Million USD -360.99%
Avidity Biosciences, Inc. 628.55 Million USD 71.632%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -842.264%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -842.264%
Sangamo Therapeutics, Inc. 165.32 Million USD -7.858%
Sol-Gel Technologies Ltd. 45.28 Million USD -293.736%
Acelyrin, Inc. 742.69 Million USD 75.991%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -2607.21%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -2684.804%
Summit Therapeutics Inc. 202.94 Million USD 12.14%
Sensei Biotherapeutics, Inc. 74.37 Million USD -139.749%
Senti Biosciences, Inc. 119.48 Million USD -49.234%
Stoke Therapeutics, Inc. 228.34 Million USD 21.911%
Syros Pharmaceuticals, Inc. 168.17 Million USD -6.028%
Alaunos Therapeutics, Inc. 8.26 Million USD -2057.945%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -3635.226%
Entrada Therapeutics, Inc. 469.19 Million USD 61.996%
VistaGen Therapeutics, Inc. 123.65 Million USD -44.203%
Wave Life Sciences Ltd. 274.94 Million USD 35.148%
Sorrento Therapeutics, Inc. 472.84 Million USD 62.289%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -1664.582%
Barinthus Biotherapeutics plc 214.5 Million USD 16.874%
Psyence Biomedical Ltd. 1.13 Million USD -15649.643%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 56.913%
Immix Biopharma, Inc. 19.92 Million USD -794.904%
Keros Therapeutics, Inc. 370.02 Million USD 51.811%
MEI Pharma, Inc. 41.37 Million USD -330.963%
Windtree Therapeutics, Inc. 32.4 Million USD -450.241%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 47.678%
Rigel Pharmaceuticals, Inc. 117.22 Million USD -52.11%
Fortress Biotech, Inc. 167.52 Million USD -6.438%
Precigen, Inc. 151.04 Million USD -18.053%
Clearside Biomedical, Inc. 34.01 Million USD -424.167%
AlloVir, Inc. 190.79 Million USD 6.544%
C4 Therapeutics, Inc. 376.45 Million USD 52.634%
Fate Therapeutics, Inc. 506.21 Million USD 64.776%
ImmuCell Corporation 43.8 Million USD -307.027%
IDEAYA Biosciences, Inc. 649.31 Million USD 72.539%
Onconetix, Inc. 88.82 Million USD -100.752%
PureTech Health plc 693.97 Million USD 74.306%
VYNE Therapeutics Inc. 97.68 Million USD -82.537%
Elevation Oncology, Inc. 89.09 Million USD -100.145%
Kintara Therapeutics, Inc. 6.2 Million USD -2775.056%
Seer, Inc. 436.26 Million USD 59.128%
Verrica Pharmaceuticals Inc. 81.59 Million USD -118.526%
Innoviva, Inc. 1.24 Billion USD 85.661%
Aadi Bioscience, Inc. 132.42 Million USD -34.653%
ESSA Pharma Inc. 149.12 Million USD -19.574%
GlycoMimetics, Inc. 45.31 Million USD -293.479%
GT Biopharma, Inc. 14.1 Million USD -1163.81%
Inhibrx Biosciences, Inc. 307.89 Million USD 42.087%
Akebia Therapeutics, Inc. 241.7 Million USD 26.227%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 62.215%
Longboard Pharmaceuticals, Inc. 50.69 Million USD -251.719%
Orchestra BioMed Holdings, Inc. 95.21 Million USD -87.278%
Alzamend Neuro, Inc. 631.58 Thousand USD -28132.17%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 68.515%
Aptose Biosciences Inc. 12.92 Million USD -1279.844%
ZyVersa Therapeutics, Inc. 22.11 Million USD -706.316%
Soligenix, Inc. 9.79 Million USD -1719.997%
Century Therapeutics, Inc. 360.69 Million USD 50.564%
Kura Oncology, Inc. 448.93 Million USD 60.281%
TScan Therapeutics, Inc. 272.14 Million USD 34.48%
Intensity Therapeutics, Inc. 17.29 Million USD -930.997%
Ocean Biomedical, Inc. 110.91 Million USD -60.769%
CytomX Therapeutics, Inc. 205.15 Million USD 13.083%
Autolus Therapeutics plc 375.38 Million USD 52.499%
Mineralys Therapeutics, Inc. 251.63 Million USD 29.139%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 49.798%
Eterna Therapeutics Inc. 49.13 Million USD -262.922%
Adaptive Biotechnologies Corporation 661.13 Million USD 73.03%
GRI Bio, Inc. 2.95 Million USD -5932.172%
Xenetic Biosciences, Inc. 10.6 Million USD -1581.35%
Tenaya Therapeutics, Inc. 170.51 Million USD -4.572%
IGM Biosciences, Inc. 423.41 Million USD 57.887%
INmune Bio, Inc. 57 Million USD -212.821%
Heron Therapeutics, Inc. 222.5 Million USD 19.862%
SAB Biotherapeutics, Inc. 83.94 Million USD -112.424%
Pasithea Therapeutics Corp. 26.11 Million USD -582.743%
Entero Therapeutics, Inc. 6.88 Million USD -2490.527%
Milestone Pharmaceuticals Inc. 75.22 Million USD -137.034%
X4 Pharmaceuticals, Inc. 147.25 Million USD -21.087%
Atara Biotherapeutics, Inc. 165.5 Million USD -7.738%
Coherus BioSciences, Inc. 629.6 Million USD 71.679%
Verastem, Inc. 149.71 Million USD -19.098%
Abeona Therapeutics Inc. 64 Million USD -178.602%
Pliant Therapeutics, Inc. 512.15 Million USD 65.184%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD -15.444%
Histogen Inc. 19.07 Million USD -834.887%
Aprea Therapeutics, Inc. 22.65 Million USD -687.239%
Surrozen, Inc. 46.08 Million USD -286.96%
Organovo Holdings, Inc. 6.34 Million USD -2708.49%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -4038.471%
Ovid Therapeutics Inc. 144.02 Million USD -23.804%
Panbela Therapeutics, Inc. 11.8 Million USD -1410.854%
CASI Pharmaceuticals, Inc. 75.26 Million USD -136.901%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -1993.036%
Centessa Pharmaceuticals plc 362.96 Million USD 50.874%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -885.449%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 58.475%
BioRestorative Therapies, Inc. 12.61 Million USD -1313.852%
Apollomics, Inc. 55.38 Million USD -221.937%
Amarin Corporation plc 831.68 Million USD 78.56%
Mesoblast Limited 669.15 Million USD 73.353%
Turnstone Biologics Corp. 112.81 Million USD -58.056%
Kymera Therapeutics, Inc. 575.75 Million USD 69.03%
Synaptogenix, Inc. 31.11 Million USD -473.095%
Tiziana Life Sciences Ltd 12.18 Million USD -1363.485%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 67.465%
BriaCell Therapeutics Corp. 5.87 Million USD -2936.497%
Monopar Therapeutics Inc. 7.34 Million USD -2327.599%
Exelixis, Inc. 2.94 Billion USD 93.94%
Better Therapeutics, Inc. 22.94 Million USD -677.191%
Nurix Therapeutics, Inc. 364.53 Million USD 51.086%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 77.393%
NLS Pharmaceutics AG 1.84 Million USD -9555.965%
Dermata Therapeutics, Inc. 7.97 Million USD -2134.856%
Aridis Pharmaceuticals, Inc. 14.69 Million USD -1113.413%
Gritstone bio, Inc. 177.76 Million USD -0.305%
Jasper Therapeutics, Inc. 95.38 Million USD -86.948%
TNF Pharmaceuticals, Inc. 17.86 Million USD -898.255%
Avid Bioservices, Inc. 336.55 Million USD 47.019%
Insmed Incorporated 1.32 Billion USD 86.592%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -1751.938%
MediWound Ltd. 66.45 Million USD -168.302%
OmniAb, Inc. 401.98 Million USD 55.642%
Alector, Inc. 621.82 Million USD 71.325%
Seres Therapeutics, Inc. 358.6 Million USD 50.276%
Checkpoint Therapeutics, Inc. 5.37 Million USD -3215.563%
Viracta Therapeutics, Inc. 56.69 Million USD -214.526%
Zai Lab Limited 1.03 Billion USD 82.793%
Revance Therapeutics, Inc. 478.45 Million USD 62.732%
Aura Biosciences, Inc. 255.07 Million USD 30.095%
Lyell Immunopharma, Inc. 750.02 Million USD 76.226%
Immunic, Inc. 54.29 Million USD -228.387%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 33.022%
Veracyte, Inc. 1.13 Billion USD 84.329%
InMed Pharmaceuticals Inc. 11.82 Million USD -1408.198%
FibroGen, Inc. 423.52 Million USD 57.899%
SeaStar Medical Holding Corporation 3.51 Million USD -4975.747%
Adial Pharmaceuticals, Inc. 4.73 Million USD -3664.532%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -3184.128%
Jazz Pharmaceuticals plc 11.39 Billion USD 98.435%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -1925.111%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 65.541%
TG Therapeutics, Inc. 329.58 Million USD 45.899%
Galecto, Inc. 38.22 Million USD -366.453%
Calithera Biosciences, Inc. 28.67 Million USD -521.813%
Fortrea Holdings Inc. 4.35 Billion USD 95.908%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 24.253%
Aptevo Therapeutics Inc. 24.84 Million USD -617.78%
XBiotech Inc. 227.24 Million USD 21.533%
Jasper Therapeutics, Inc. 95.38 Million USD -86.948%
Lyra Therapeutics, Inc. 142.6 Million USD -25.043%
Foghorn Therapeutics Inc. 285.91 Million USD 37.635%
Y-mAbs Therapeutics, Inc. 127.86 Million USD -39.448%
Theravance Biopharma, Inc. 381.99 Million USD 53.322%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 88.041%
Metagenomi, Inc. Common Stock 364.84 Million USD 51.127%
Vaxxinity, Inc. 44.35 Million USD -302.027%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 65.508%
Gain Therapeutics, Inc. 18.6 Million USD -858.181%
Cartesian Therapeutics, Inc. 305.05 Million USD 41.547%
NexImmune, Inc. 8.59 Million USD -1974.844%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -1564.096%
Marker Therapeutics, Inc. 17.12 Million USD -941.087%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.461%
Chemomab Therapeutics Ltd. 22.15 Million USD -704.975%
Scopus BioPharma Inc. 392.26 Thousand USD -45356.77%
RAPT Therapeutics, Inc. 173.32 Million USD -2.874%
Ainos, Inc. 31.84 Million USD -459.99%
Pluri Inc. 39.52 Million USD -351.112%
Prothena Corporation plc 696.38 Million USD 74.395%
Adaptimmune Therapeutics plc 282.61 Million USD 36.907%
Celularity Inc. 143.88 Million USD -23.923%
Rallybio Corporation 115.62 Million USD -54.222%
Cue Biopharma, Inc. 61.53 Million USD -189.795%
MeiraGTx Holdings plc 458.16 Million USD 61.082%
Omeros Corporation 378.26 Million USD 52.861%
Humacyte, Inc. 128.22 Million USD -39.063%
Immunocore Holdings plc 597 Million USD 70.132%
Cocrystal Pharma, Inc. 31.25 Million USD -470.431%
Cidara Therapeutics, Inc. 68.53 Million USD -160.194%
Blueprint Medicines Corporation 1.04 Billion USD 83.006%
CalciMedica, Inc. 12.18 Million USD -1363.365%
Cabaletta Bio, Inc. 253.65 Million USD 29.702%
Marinus Pharmaceuticals, Inc. 170.9 Million USD -4.332%
Scholar Rock Holding Corporation 311.03 Million USD 42.672%
Sana Biotechnology, Inc. 565.29 Million USD 68.457%
Pulmatrix, Inc. 33.95 Million USD -425.093%
Elicio Therapeutics, Inc. 27.14 Million USD -556.859%
Vigil Neuroscience, Inc. 140.85 Million USD -26.589%
Intellia Therapeutics, Inc. 1.3 Billion USD 86.294%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD -36.963%
Cytokinetics, Incorporated 824.31 Million USD 78.369%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD -744.156%
Nutriband Inc. 7.51 Million USD -2272.055%
Protara Therapeutics, Inc. 78.95 Million USD -125.842%
Vor Biopharma Inc. 209.82 Million USD 15.02%
Roivant Sciences Ltd. 7.22 Billion USD 97.531%
Evogene Ltd. 51.1 Million USD -248.938%
ProKidney Corp. 420.55 Million USD 57.601%
Applied Therapeutics, Inc. 54.83 Million USD -225.189%
Hoth Therapeutics, Inc. 9.52 Million USD -1772.96%
BridgeBio Pharma, Inc. 546.38 Million USD 67.365%
CorMedix Inc. 82.05 Million USD -117.294%
BioLineRx Ltd. 63.92 Million USD -178.938%
Tango Therapeutics, Inc. 402.56 Million USD 55.707%
Galectin Therapeutics Inc. 28.2 Million USD -532.309%
Atai Life Sciences N.V. 293.47 Million USD 39.242%
Renovaro Biosciences Inc. 163.12 Million USD -9.306%
Aerovate Therapeutics, Inc. 127.41 Million USD -39.942%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 68.274%
Sagimet Biosciences Inc. 96.71 Million USD -84.36%
MediciNova, Inc. 66.26 Million USD -169.068%
Praxis Precision Medicines, Inc. 87.94 Million USD -102.746%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -3895.886%
GeoVax Labs, Inc. 9.28 Million USD -1820.788%
Axsome Therapeutics, Inc. 588.23 Million USD 69.687%
Biomea Fusion, Inc. 199.92 Million USD 10.812%
PTC Therapeutics, Inc. 1.9 Billion USD 90.631%
Mereo BioPharma Group plc 66.49 Million USD -168.141%
Cullinan Oncology, Inc. 485.09 Million USD 63.242%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 70.906%
Absci Corporation 234.48 Million USD 23.955%
NRx Pharmaceuticals, Inc. 7.31 Million USD -2337.608%
4D Molecular Therapeutics, Inc. 339.89 Million USD 47.539%
Dyne Therapeutics, Inc. 165.08 Million USD -8.014%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 66.121%
Ventyx Biosciences, Inc. 277.69 Million USD 35.788%
Allakos Inc. 243.61 Million USD 26.805%
Imunon, Inc. 21.91 Million USD -713.534%
Fulcrum Therapeutics, Inc. 257.69 Million USD 30.805%
Corcept Therapeutics Incorporated 621.51 Million USD 71.31%
BioAtla, Inc. 119.65 Million USD -49.017%
NLS Pharmaceutics AG 1.84 Million USD -9555.965%
Bio-Path Holdings, Inc. 3.22 Million USD -5437.609%
Allogene Therapeutics, Inc. 642.83 Million USD 72.262%
Larimar Therapeutics, Inc. 95.93 Million USD -85.866%
XOMA Corporation 234.3 Million USD 23.897%
Kezar Life Sciences, Inc. 221.23 Million USD 19.402%
Cara Therapeutics, Inc. 125.84 Million USD -41.692%
aTyr Pharma, Inc. 122.06 Million USD -46.076%
Aligos Therapeutics, Inc. 153.9 Million USD -15.859%
Akero Therapeutics, Inc. 580.27 Million USD 69.271%
Viridian Therapeutics, Inc. 490.42 Million USD 63.641%
Eliem Therapeutics, Inc. 110.46 Million USD -61.413%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -1076.383%
Akari Therapeutics, Plc 4.35 Million USD -3994.397%
Tevogen Bio Holdings Inc. 17.03 Million USD -946.59%
Halozyme Therapeutics, Inc. 1.73 Billion USD 89.712%
Lexaria Bioscience Corp. 3.08 Million USD -5681.836%
Sutro Biopharma, Inc. 470.73 Million USD 62.121%
ZIVO Bioscience, Inc. 555.71 Thousand USD -31986.771%
Orgenesis Inc. 14.55 Million USD -1125.337%
Entera Bio Ltd. 11.76 Million USD -1415.606%
GH Research PLC 226.3 Million USD 21.206%
Lisata Therapeutics, Inc. 54.69 Million USD -226.016%
Reneo Pharmaceuticals, Inc. 107.43 Million USD -65.97%
Xencor, Inc. 952.69 Million USD 81.283%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -2190.805%
Replimune Group, Inc. 487.72 Million USD 63.44%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -2109.256%
Vanda Pharmaceuticals Inc. 648.44 Million USD 72.502%
Lexaria Bioscience Corp. 3.08 Million USD -5681.836%
Portage Biotech Inc. 7.77 Million USD -2192.21%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -3895.886%
Olema Pharmaceuticals, Inc. 276.94 Million USD 35.615%
OncoCyte Corporation 74.89 Million USD -138.091%
Qualigen Therapeutics, Inc. 2.03 Million USD -8669.761%
Processa Pharmaceuticals, Inc. 5.78 Million USD -2981.424%
Purple Biotech Ltd. 44.3 Million USD -302.49%
CollPlant Biotechnologies Ltd. 34.12 Million USD -422.508%
scPharmaceuticals Inc. 94.47 Million USD -88.731%
ProMIS Neurosciences, Inc. 18.04 Million USD -888.149%
HilleVax, Inc. 344.43 Million USD 48.231%
NeuroSense Therapeutics Ltd. 3.17 Million USD -5514.326%
Tharimmune, Inc. 10.94 Million USD -1528.948%
Genprex, Inc. 10.67 Million USD -1571.051%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 64.064%
Atossa Therapeutics, Inc. 96.25 Million USD -85.254%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -7250.0%
Virios Therapeutics, Inc. 4.16 Million USD -4180.723%
OKYO Pharma Limited 1.54 Million USD -11469.141%
Savara Inc. 177.56 Million USD -0.421%
Curis, Inc. 77.28 Million USD -130.728%
Daré Bioscience, Inc. 21.28 Million USD -737.84%
Carmell Therapeutics Corporation 63.94 Million USD -178.834%
Titan Pharmaceuticals, Inc. 8.08 Million USD -2105.182%
Achieve Life Sciences, Inc. 19.37 Million USD -820.505%
BeiGene, Ltd. 5.8 Billion USD 96.928%
Kiromic BioPharma, Inc. 12.16 Million USD -1365.289%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 91.463%
Protagonist Therapeutics, Inc. 357.95 Million USD 50.186%
Erasca, Inc. 395.29 Million USD 54.892%
bluebird bio, Inc. 619.16 Million USD 71.201%
Protagenic Therapeutics, Inc. 4.32 Million USD -4024.353%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 97.394%
DBV Technologies S.A. 182.98 Million USD 2.555%
Protagenic Therapeutics, Inc. 4.32 Million USD -4024.353%
Moderna, Inc. 18.42 Billion USD 99.032%
Vincerx Pharma, Inc. 18.21 Million USD -878.816%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -1439.021%
Molecular Templates, Inc. 35.38 Million USD -403.945%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD -28.963%
Travere Therapeutics, Inc. 788.91 Million USD 77.398%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 41.298%
Spruce Biosciences, Inc. 103.94 Million USD -71.542%
Celldex Therapeutics, Inc. 465.62 Million USD 61.705%
Cogent Biosciences, Inc. 313.43 Million USD 43.111%
MacroGenics, Inc. 306.82 Million USD 41.884%
RenovoRx, Inc. 1.46 Million USD -12063.097%
Adicet Bio, Inc. 207.29 Million USD 13.982%
Prime Medicine, Inc. 193.85 Million USD 8.016%
Aditxt, Inc. 44.57 Million USD -299.995%
Adagene Inc. 115.72 Million USD -54.077%
Estrella Immunopharma, Inc. 4.45 Million USD -3903.22%
Quantum-Si incorporated 298.25 Million USD 40.214%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 88.012%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -2212.987%
Voyager Therapeutics, Inc. 351.28 Million USD 49.24%
SciSparc Ltd. 11.18 Million USD -1494.625%
Vericel Corporation 353.65 Million USD 49.581%
Revelation Biosciences, Inc. 12.21 Million USD -1360.057%
Minerva Neurosciences, Inc. 56.9 Million USD -213.373%
Generation Bio Co. 374.75 Million USD 52.42%
Astria Therapeutics, Inc. 254.66 Million USD 29.982%
Black Diamond Therapeutics, Inc. 158.56 Million USD -12.452%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 47.765%
Invivyd, Inc. 229.18 Million USD 22.196%
Relay Therapeutics, Inc. 843.98 Million USD 78.873%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -1365.253%
Spero Therapeutics, Inc. 182.39 Million USD 2.236%
Artelo Biosciences, Inc. 20.42 Million USD -773.046%
2seventy bio, Inc. 565.42 Million USD 68.464%
ADMA Biologics, Inc. 329.18 Million USD 45.832%
Clene Inc. 52.34 Million USD -240.672%
Capricor Therapeutics, Inc. 58.73 Million USD -203.589%
Boundless Bio, Inc. Common Stock 129.89 Million USD -37.274%
GeoVax Labs, Inc. 9.28 Million USD -1820.788%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 72.723%
Citius Pharmaceuticals, Inc. 103.61 Million USD -72.096%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD -36.756%
Relmada Therapeutics, Inc. 97.55 Million USD -82.786%
Finch Therapeutics Group, Inc. 70.99 Million USD -151.153%
ALX Oncology Holdings Inc. 242.55 Million USD 26.486%
Vir Biotechnology, Inc. 1.96 Billion USD 90.903%
Evaxion Biotech A/S 12.88 Million USD -1283.476%
Ocular Therapeutix, Inc. 252.06 Million USD 29.259%
Verve Therapeutics, Inc. 752.68 Million USD 76.31%
Trevena, Inc. 40.6 Million USD -339.136%
Surrozen, Inc. 46.08 Million USD -286.96%
Tyra Biosciences, Inc. 225.85 Million USD 21.051%
Cingulate Inc. 3.49 Million USD -5007.096%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -972.289%
Unity Biotechnology, Inc. 65.69 Million USD -171.443%
Tenax Therapeutics, Inc. 11.68 Million USD -1426.031%
Terns Pharmaceuticals, Inc. 268.51 Million USD 33.594%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 76.192%
Connect Biopharma Holdings Limited 125.89 Million USD -41.638%
Clearmind Medicine Inc. 4.32 Million USD -4023.38%
Kronos Bio, Inc. 213.27 Million USD 16.395%
Bolt Biotherapeutics, Inc. 159.78 Million USD -11.595%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1982.924%
Viking Therapeutics, Inc. 368.49 Million USD 51.61%
Statera Biopharma, Inc. 21.16 Million USD -742.294%
ImmunityBio, Inc. 504.45 Million USD 64.653%
Korro Bio, Inc. 221.66 Million USD 19.558%
Kineta, Inc. 10.28 Million USD -1634.374%
BioVie Inc. 25.2 Million USD -607.349%
Codexis, Inc. 136.56 Million USD -30.572%
Celularity Inc. 143.88 Million USD -23.923%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 71.935%
Celcuity Inc. 191.21 Million USD 6.751%
Virax Biolabs Group Limited 5.48 Million USD -3151.495%
Cibus, Inc. 544.41 Million USD 67.247%
Eledon Pharmaceuticals, Inc. 125.89 Million USD -41.636%
eFFECTOR Therapeutics, Inc. 20.54 Million USD -767.947%
IN8bio, Inc. 33.7 Million USD -428.971%
Kodiak Sciences Inc. 479.37 Million USD 62.803%
Annexon, Inc. 297.67 Million USD 40.099%
Adverum Biotechnologies, Inc. 173.01 Million USD -3.064%
Assembly Biosciences, Inc. 137.46 Million USD -29.71%
Avalo Therapeutics, Inc. 20.99 Million USD -749.383%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 94.037%
Eyenovia, Inc. 28.77 Million USD -519.579%
Puma Biotechnology, Inc. 230.52 Million USD 22.651%
Conduit Pharmaceuticals Inc. 7.22 Million USD -2368.314%
Xilio Therapeutics, Inc. 60.92 Million USD -192.668%
Arcellx, Inc. 825.13 Million USD 78.39%
Cardiff Oncology, Inc. 81.63 Million USD -118.419%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 61.428%
Regulus Therapeutics Inc. 30.75 Million USD -479.873%
Moolec Science SA 24.05 Million USD -641.378%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 42.504%
Geron Corporation 394.07 Million USD 54.752%
LAVA Therapeutics N.V. 101.71 Million USD -75.313%
Royalty Pharma plc 16.38 Billion USD 98.912%
Atea Pharmaceuticals, Inc. 594.96 Million USD 70.03%
Greenwich LifeSciences, Inc. 6.99 Million USD -2449.188%
TFF Pharmaceuticals, Inc. 12.02 Million USD -1382.55%
Mersana Therapeutics, Inc. 226.06 Million USD 21.122%
Humacyte, Inc. 128.22 Million USD -39.063%
Structure Therapeutics Inc. 482.01 Million USD 63.007%
89bio, Inc. 596.26 Million USD 70.096%
PMV Pharmaceuticals, Inc. 252.15 Million USD 29.284%
Avenue Therapeutics, Inc. 1.85 Million USD -9538.432%
Genelux Corporation 27.89 Million USD -539.268%
Trevi Therapeutics, Inc. 89.4 Million USD -99.446%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 22.281%
Notable Labs, Ltd. 19.54 Million USD -812.497%
Liquidia Corporation 120.43 Million USD -48.061%
Mustang Bio, Inc. 17.74 Million USD -905.022%
Immunovant, Inc. 666.71 Million USD 73.255%
Quantum-Si incorporated 298.25 Million USD 40.214%
Arbutus Biopharma Corporation 144.4 Million USD -23.483%
DiaMedica Therapeutics Inc. 54.16 Million USD -229.23%
Vera Therapeutics, Inc. 175.54 Million USD -1.575%
Acasti Pharma Inc. 73.3 Million USD -143.262%
MiNK Therapeutics, Inc. 4.55 Million USD -3816.959%
Pasithea Therapeutics Corp. 26.11 Million USD -582.743%
Xenon Pharmaceuticals Inc. 964.79 Million USD 81.518%
Elevai Labs, Inc. Common Stock 5.18 Million USD -3335.719%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD -682.718%
Tempest Therapeutics, Inc. 51.6 Million USD -245.544%
Soleno Therapeutics, Inc. 180.69 Million USD 1.317%
PepGen Inc. 143.05 Million USD -24.648%
Moleculin Biotech, Inc. 38.21 Million USD -366.575%
United Therapeutics Corporation 7.16 Billion USD 97.512%
Nuvectis Pharma, Inc. 19.18 Million USD -829.429%
Solid Biosciences Inc. 164.93 Million USD -8.107%
BriaCell Therapeutics Corp. 5.87 Million USD -2936.497%
Immuneering Corporation 102.58 Million USD -73.819%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -4038.471%
Silo Pharma, Inc. 7.74 Million USD -2201.933%
Belite Bio, Inc 94.64 Million USD -88.406%
XOMA Corporation 234.3 Million USD 23.897%
ARS Pharmaceuticals, Inc. 233.18 Million USD 23.533%
Bionomics Limited 27.64 Million USD -544.907%
Apogee Therapeutics, Inc. 401.4 Million USD 55.578%
Alpha Tau Medical Ltd. 107.38 Million USD -66.044%
uniQure N.V. 831.68 Million USD 78.56%
Cassava Sciences, Inc. 151.66 Million USD -17.571%
Estrella Immunopharma, Inc. 4.45 Million USD -3903.22%
Poseida Therapeutics, Inc. 273.88 Million USD 34.896%
Forte Biosciences, Inc. 38.98 Million USD -357.442%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -4277.756%
Enlivex Therapeutics Ltd. 36.83 Million USD -384.133%
Conduit Pharmaceuticals Inc. 7.22 Million USD -2368.314%
SeaStar Medical Holding Corporation 3.51 Million USD -4975.747%
FibroBiologics, Inc. Common Stock 11.82 Million USD -1408.426%
Altimmune, Inc. 210.64 Million USD 15.348%
Amicus Therapeutics, Inc. 777.88 Million USD 77.077%
Alpha Tau Medical Ltd. 107.38 Million USD -66.044%
Compugen Ltd. 121.33 Million USD -46.959%
Peak Bio, Inc. 2.59 Million USD -6767.585%
Zevra Therapeutics, Inc. 172.32 Million USD -3.472%
Benitec Biopharma Inc. 52.21 Million USD -241.527%
Spyre Therapeutics, Inc. 341.85 Million USD 47.841%
NKGen Biotech, Inc. Common Stock 34.77 Million USD -412.786%
Zura Bio Limited 100.84 Million USD -76.82%
PolyPid Ltd. 15.37 Million USD -1059.973%
Aileron Therapeutics, Inc. 119.28 Million USD -49.482%
NKGen Biotech, Inc. Warrants 34.77 Million USD -412.786%
Instil Bio, Inc. 325.63 Million USD 45.241%
argenx SE 4.54 Billion USD 96.075%
Immunome, Inc. 148.54 Million USD -20.042%
Compass Therapeutics, Inc. 156.87 Million USD -13.664%
Verona Pharma plc 308.12 Million USD 42.13%
enGene Holdings Inc. Warrants 86.95 Million USD -105.052%
Shattuck Labs, Inc. 159.56 Million USD -11.749%
CervoMed Inc. 9.97 Million USD -1688.023%
LENZ Therapeutics, Inc. 188.45 Million USD 5.383%
Plus Therapeutics, Inc. 11.38 Million USD -1465.78%
Dianthus Therapeutics, Inc. 179.4 Million USD 0.61%
Moolec Science SA 24.05 Million USD -641.378%
Enveric Biosciences, Inc. 6.11 Million USD -2814.779%
Inovio Pharmaceuticals, Inc. 172.94 Million USD -3.103%
AnaptysBio, Inc. 452.38 Million USD 60.585%
Design Therapeutics, Inc. 289.64 Million USD 38.438%
Leap Therapeutics, Inc. 72.82 Million USD -144.849%
NeurAxis, Inc. 509.49 Thousand USD -34897.39%
Seelos Therapeutics, Inc. 5.41 Million USD -3191.085%
Lumos Pharma, Inc. 40.63 Million USD -338.779%
Achilles Therapeutics plc 161.45 Million USD -10.439%
enGene Holdings Inc. Common Stock 86.95 Million USD -105.052%
180 Life Sciences Corp. 5.25 Million USD -3290.281%
Opiant Pharmaceuticals, Inc. 70.42 Million USD -153.183%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1982.924%
Nutriband Inc. 7.51 Million USD -2272.055%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 29.988%
CG Oncology, Inc. Common stock 199.3 Million USD 10.532%
Fractyl Health, Inc. Common Stock 76.21 Million USD -133.967%
Rani Therapeutics Holdings, Inc. 57.91 Million USD -207.879%
MoonLake Immunotherapeutics 526.54 Million USD 66.135%
Palisade Bio, Inc. 14.05 Million USD -1168.937%
Tourmaline Bio, Inc. 210.29 Million USD 15.209%
Beam Therapeutics Inc. 1.45 Billion USD 87.785%
Neurogene Inc. 222.57 Million USD 19.887%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 72.424%
AEON Biopharma, Inc. 6.84 Million USD -2504.982%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 60.641%
Sesen Bio, Inc. 189.17 Million USD 5.742%
Enliven Therapeutics, Inc. 271.86 Million USD 34.412%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -1200.413%
Iovance Biotherapeutics, Inc. 780.35 Million USD 77.15%
Taysha Gene Therapies, Inc. 266.99 Million USD 33.215%
Athira Pharma, Inc. 160.24 Million USD -11.274%
Vaccinex, Inc. 3.63 Million USD -4810.796%
HCW Biologics Inc. 28.51 Million USD -525.353%
XOMA Corporation 234.3 Million USD 23.897%
Nektar Therapeutics 398.03 Million USD 55.202%
Arvinas, Inc. 1.3 Billion USD 86.332%
Tevogen Bio Holdings Inc. 17.03 Million USD -946.59%
Merus N.V. 458.49 Million USD 61.109%
Omega Therapeutics, Inc. 204.36 Million USD 12.749%
Quince Therapeutics, Inc. 180.2 Million USD 1.05%
Rezolute, Inc. 132.73 Million USD -34.334%
Clene Inc. 52.34 Million USD -240.672%
Indaptus Therapeutics, Inc. 14.92 Million USD -1094.803%
BeyondSpring Inc. 24.8 Million USD -618.764%
Synlogic, Inc. 75.55 Million USD -136.017%
Allarity Therapeutics, Inc. 11.86 Million USD -1403.212%
Phio Pharmaceuticals Corp. 9.36 Million USD -1804.218%
Peak Bio, Inc. 2.59 Million USD -6767.585%
Werewolf Therapeutics, Inc. 174.83 Million USD -1.989%
Krystal Biotech, Inc. 818.35 Million USD 78.211%
Karyopharm Therapeutics Inc. 240.43 Million USD 25.839%
SpringWorks Therapeutics, Inc. 725.78 Million USD 75.432%
Lipella Pharmaceuticals Inc. 3.57 Million USD -4884.689%
MannKind Corporation 475.19 Million USD 62.476%
Ikena Oncology, Inc. 192.09 Million USD 7.174%
Cyclerion Therapeutics, Inc. 13.37 Million USD -1233.266%
Gyre Therapeutics, Inc. 116.53 Million USD -53.005%
Gossamer Bio, Inc. 311.91 Million USD 42.834%
CohBar, Inc. 16.36 Million USD -989.543%
Cognition Therapeutics, Inc. 35.16 Million USD -407.098%
NRx Pharmaceuticals, Inc. 7.31 Million USD -2337.608%
Legend Biotech Corporation 1.84 Billion USD 90.354%
Mural Oncology plc 301.74 Million USD 40.907%
Biora Therapeutics, Inc. 31.21 Million USD -471.235%
PaxMedica, Inc. Common Stock 5.68 Million USD -3039.054%
Disc Medicine, Inc. 367.99 Million USD 51.545%
Champions Oncology, Inc. 26.13 Million USD -582.347%
REGENXBIO Inc. 573.97 Million USD 68.934%
Ensysce Biosciences, Inc. 2.7 Million USD -6484.395%
Anavex Life Sciences Corp. 154.38 Million USD -15.497%
Cellectar Biosciences, Inc. 12.07 Million USD -1376.625%
Edgewise Therapeutics, Inc. 340.03 Million USD 47.561%
Vaxart, Inc. 91.83 Million USD -94.175%
PharmaCyte Biotech, Inc. 59.9 Million USD -197.662%
Aldeyra Therapeutics, Inc. 148.32 Million USD -20.215%
Cellectis S.A. 334.27 Million USD 46.657%
Longeveron Inc. 12.17 Million USD -1364.206%
Repare Therapeutics Inc. 253.9 Million USD 29.771%
Sarepta Therapeutics, Inc. 3.26 Billion USD 94.538%
Inozyme Pharma, Inc. 200.84 Million USD 11.22%
Revolution Medicines, Inc. 2.08 Billion USD 91.463%
Nymox Pharmaceutical Corporation 1.62 Million USD -10872.985%
Third Harmonic Bio, Inc. 277.71 Million USD 35.793%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD -9.328%
AN2 Therapeutics, Inc. 138.74 Million USD -28.518%
Anixa Biosciences, Inc. 25.52 Million USD -598.656%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.216%
Denali Therapeutics Inc. 1.15 Billion USD 84.547%
Revelation Biosciences, Inc. 12.21 Million USD -1360.057%
Veru Inc. 50.59 Million USD -252.422%
Corvus Pharmaceuticals, Inc. 45.55 Million USD -291.436%
Cingulate Inc. 3.49 Million USD -5007.096%
Passage Bio, Inc. 150.54 Million USD -18.444%
Context Therapeutics Inc. 16.06 Million USD -1010.091%
Exicure, Inc. 11.58 Million USD -1439.819%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 52.583%
Oramed Pharmaceuticals Inc. 161.64 Million USD -10.312%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -920.553%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 46.412%
Nuvalent, Inc. 732.38 Million USD 75.653%
ABVC BioPharma, Inc. 14.94 Million USD -1093.188%
Carisma Therapeutics, Inc. 89.55 Million USD -99.11%
Unicycive Therapeutics, Inc. 14.19 Million USD -1156.508%
OmniAb, Inc. 401.98 Million USD 55.642%
Anew Medical, Inc. 19.45 Million USD -816.486%
Fennec Pharmaceuticals Inc. 26.72 Million USD -567.168%
Lipocine Inc. 23 Million USD -675.229%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD -27.541%
Nautilus Biotechnology, Inc. 305.56 Million USD 41.645%
SAB Biotherapeutics, Inc. 83.94 Million USD -112.424%
G1 Therapeutics, Inc. 121.54 Million USD -46.71%
Bellerophon Therapeutics, Inc. 7.93 Million USD -2147.146%
Sage Therapeutics, Inc. 882.27 Million USD 79.79%
Ocugen, Inc. 64.54 Million USD -176.25%
Mind Medicine (MindMed) Inc. 124.54 Million USD -43.175%
Q32 Bio Inc. 306.11 Million USD 41.751%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -4137.429%
Alumis Inc. Common Stock 89.61 Million USD -98.981%
Equillium, Inc. 50.53 Million USD -252.881%
Kyverna Therapeutics, Inc. 75.19 Million USD -137.131%
Coya Therapeutics, Inc. 41.27 Million USD -332.023%
CNS Pharmaceuticals, Inc. 1.7 Million USD -10383.622%
Galera Therapeutics, Inc. 26.14 Million USD -582.112%
Evelo Biosciences, Inc. 64.44 Million USD -176.704%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -4684.159%
Dominari Holdings Inc. 57.55 Million USD -209.794%
Edesa Biotech, Inc. 8.89 Million USD -1905.649%
vTv Therapeutics Inc. 11.01 Million USD -1518.361%
Bio-Techne Corporation 2.81 Billion USD 93.662%
Agios Pharmaceuticals, Inc. 937.11 Million USD 80.972%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 78.026%
Prelude Therapeutics Incorporated 277.66 Million USD 35.782%
Candel Therapeutics, Inc. 41.7 Million USD -327.584%
iTeos Therapeutics, Inc. 667.58 Million USD 73.29%
Nkarta, Inc. 378.88 Million USD 52.938%
BioCardia, Inc. 2.98 Million USD -5869.568%
Iterum Therapeutics plc 26.25 Million USD -579.047%